Ned Wydysh

Aa decision-resources analyst and co-leader of Health Advances’ oncology and cell and gene therapy practices, Ned specializes in portfolio planning and new-opportunity assessment across therapeutic areas. His focuses include oncology, orphaned and genetic diseases, neuroscience, and autoimmune diseases; he also supports development strategies for the advancement and commercialization of novel therapeutics, including benchmarking, new product planning, market evaluation, and forecasting. Ned has two degrees in chemistry: a BA from Williams College and a doctorate from John Hopkins University.